neurodiem-image

Screening newborns for SMA: experiences from a pilot program

We started the pilot project about 2 years ago. I work in a newborn screening laboratory in Belgium, and we had been contacted by a neurophysician who takes care of patients with spinal muscular atrophy (SMA). He wanted to implement a new screening program for SMA, and showed us videos of the effects of the new treatments available today. We were all very enthusiastic and started with the development of a screening assay in the laboratory in September 2017.